Among them, a total of 24 genes, namely CASP1, CASP3, CASP4, CASP5, CASP6, CASP8, CASP9, GSDMA, GSDMB, GSDMC, GSDMD, GSDME, IL18, IL1B, NLRC4, NLRP1, NLRP2, NLRP3, NLRP7, NOD1, PLCG1, PRKACA, PYCARD, and SCAF11, exhibited significant enrichment in the tumor group. This evidence concerns the gene PLCG1 and neoplasm.